Trodelvy expanded to 1L metastatic TNBC Across PD-L1 Status in the EU

Novartis’ Pluvicto receives approval in China for a new indication

DualityBio’s DB-1317 granted FDA Fast Track Designation for advanced PDAC

SOTIO’s SOT106 granted FDA Fast Track Designation for Soft Tissue Sarcoma

Datroway phase 3 TROPION-Urothelial04 trial initiated as adjuvant therapy for high-risk MIUC

CSPC announced that SYS6010 met the pre-specified primary endpoint in phase 3 trial